G1 Therapeutics Inc (NAS:GTHX)
$ 7.15 0 (0%) Market Cap: 377.22 Mil Enterprise Value: 364.45 Mil PE Ratio: 0 PB Ratio: 15.31 GF Score: 31/100

Q1 2019 G1 Therapeutics Inc Earnings Call Transcript

May 09, 2019 / 08:30PM GMT
Release Date Price: $20.69 (-1.05%)
Operator

Good afternoon, ladies and gentlemen, and welcome to G1 First Quarter 2019 Corporate and Financial Update Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded.

I would now like to turn the conference over to your host, Mr. Jeff Macdonald, Head of Investor Relations. The floor is yours.

Jeff Macdonald
G1 Therapeutics, Inc. - Head of Investor & Public Relations

Thank you, operator. Good afternoon, everyone, and welcome to the G1 Therapeutics First Quarter 2019 Update. Joining me are Mark Velleca, Chief Executive Officer; and Raj Malik, Chief Medical Officer and Senior Vice President R&D. I'm also pleased to introduce Jen Moses, our Chief Financial Officer. John Demaree, our Chief Commercial Officer, will be available during the Q&A session.

Before we begin, I would like to remind you that today's call will include forward-looking statements based on current expectations. Such statements represent management's judgment as of today and may involve risks and uncertainties that could cause

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot